
Mid-sized firms with 100–500 employees face a structural vulnerability to unmanaged health liabilities — including sickness absence, long-term incapacity and related employment claims — because of their scale and resource profile. They are typically too large to rely on informal absence management, yet too small to sustain the in-house occupational health, legal and risk infrastructure common in larger enterprises.
Evidence from Unum UK shows that sickness absence carries substantial cost for SMEs, with a median annual cost of £27,964 — equivalent to 1.7% of turnover — and an estimated £28.9 billion nationally across the SME population. With SMEs accounting for 99.9% of UK businesses, according to the Department for Business and Trade, unmanaged health risk is not marginal; it is systemic.
Defining Health Liabilities in SMEs
Health liabilities extend beyond statutory sick pay. They include:
- Direct wage costs and sick pay
- Temporary staffing or overtime cover
- Reduced productivity (presenteeism and absence spill-over)
- Management time and operational disruption
- Legal exposure under employment and health and safety law
Under the Employers’ Liability (Compulsory Insurance) Act 1969, UK employers must hold at least £5 million of employers’ liability insurance. The Health and Safety Executive can issue fines of up to £2,500 per day for failure to hold appropriate cover, alongside £1,000 for failing to display a valid certificate.
Mental ill-health, stress and chronic conditions are increasingly prominent drivers of absence. Data from the Office for National Statistics shows that long-term sickness levels have risen in recent years, with mental health conditions a significant contributor to economic inactivity. For SMEs operating on tighter margins, sustained long-term absence can rapidly escalate from a people issue into a balance-sheet risk.
The ‘Goldilocks’ Vulnerability of Mid-Sized Firms
Firms with 100–500 staff sit in a precarious middle ground:
- Micro and small businesses (<50 staff) often manage absence directly and personally, limiting structural complexity.
- Large enterprises (>500 staff) are more likely to operate formal occupational health (OH) services, employee assistance programmes (EAPs), structured return-to-work pathways and legal compliance teams.
The Institution of Occupational Safety and Health notes that smaller businesses are less likely to have formal occupational safety and health systems in place. Meanwhile, government research from the Department for Work and Pensions indicates that provision of health and wellbeing support increases with employer size, particularly beyond the micro-business threshold.
Mid-sized firms often invest reactively rather than strategically. They may offer some wellbeing provision, but without integrated absence analytics, early OH intervention, or structured risk management frameworks. This results in:
- Higher per-employee impact when key individuals are absent
- Limited purchasing power for comprehensive group insurance or OH contracts
- Greater exposure to single-event disruption
Quantifying the Financial Toll
Unum’s SME research indicates that long-term absence (typically defined as four weeks or more) can cost over £20,000 per employee when factoring in cover, lost output and productivity effects. Even short-term absence imposes significant cumulative cost.
The financial impact is not evenly distributed. In a 120-person professional services firm, the prolonged absence of one senior specialist may disrupt client delivery, revenue and team capacity in a way that would be absorbed more easily within a 5,000-employee organisation.
Furthermore, occupational health access is uneven. Research cited by industry bodies suggests that only around half of UK workers have access to formal occupational health services, with coverage significantly higher in large organisations than in SMEs. That disparity leaves mid-sized firms managing complex medical issues without specialist clinical guidance.
Underinsurance and Legal Exposure
Underinsurance remains a documented issue in the SME market. Risk advisory reporting from major insurers, including Aviva, has highlighted growing concern around underinsurance among SMEs facing economic pressure.
Misunderstanding around employers’ liability, public liability and employment practices risk can leave firms exposed to:
- Discrimination or unfair dismissal claims linked to health conditions
- Failure to make reasonable adjustments under equality legislation
- Enforcement action for health and safety breaches
Larger firms typically retain in-house legal or compliance teams; mid-sized businesses frequently rely on external advisers, increasing lag time between risk emergence and risk mitigation.
Common Oversights Fuel the Gap
Research from the Department for Work and Pensions on SME uptake of wellbeing support identifies recurring barriers:
- Lack of expertise
- Time constraints
- Limited capital allocation
- Uncertainty about return on investment
Four in ten SMEs report being under strain from sickness absence, yet a notable minority take no structured action to address it. In growth-phase firms, leadership attention is often directed towards revenue, headcount and expansion, rather than absence analytics or preventive health strategy.
This creates a risk inflection point: as headcount rises beyond 100 employees, informal management systems become insufficient, yet formal infrastructure has not fully matured.
Regulatory Landscape and Structural Pressures
The regulatory baseline is clear: employers must manage workplace risk, hold appropriate insurance and support safe working environments. The Health and Safety Executive continues to emphasise employer responsibility for managing work-related stress as part of its Management Standards framework.
At the macro level, the Office for National Statistics has reported sustained levels of economic inactivity linked to long-term sickness, reinforcing the strategic importance of workforce health to productivity and national growth.
For mid-sized firms, this means health risk is no longer purely operational — it is strategic and regulatory.
Bridging the Mid-Market Risk Gap
Evidence from government and insurer research consistently suggests that early intervention and structured support reduce absence duration and cost. Practical steps grounded in existing UK guidance include:
- Formal absence analytics and early intervention triggers
Using structured monitoring aligned with ACAS and HSE guidance.
- Review of employers’ liability and group risk cover
Ensuring compliance with statutory requirements and appropriate income protection provision.
- Targeted mental health and stress management support
In line with HSE Management Standards.
- Access to occupational health referral pathways
Particularly for long-term or complex cases.
- Clear return-to-work planning
Including reasonable adjustments where required under equality legislation.
Government publications from the Department for Work and Pensions emphasise that even relatively low-cost wellbeing interventions can improve retention and reduce absence where implemented consistently.
Conclusion: A Structural, Not Behavioural, Risk
The vulnerability of 100–500 employee firms is not a failure of intent; it is a structural exposure created by scale without infrastructure.
They are:
- Large enough for absence to become systemic
- Small enough for each prolonged case to materially affect operations
- Often under-resourced relative to enterprise competitors
With sickness absence costing SMEs billions annually and long-term health conditions rising across the UK workforce, mid-sized firms represent the most exposed segment of the employer market.
For this group, workforce health is not simply a wellbeing initiative — it is a financial control mechanism, a compliance requirement and a strategic resilience issue.